Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Profit After Tax: 2009-2024

Historic Profit After Tax for Cytokinetics (CYTK) over the last 16 years, with Dec 2024 value amounting to -$589.5 million.

  • Cytokinetics' Profit After Tax fell 90.71% to -$306.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$752.0 million, marking a year-over-year decrease of 30.46%. This contributed to the annual value of -$589.5 million for FY2024, which is 12.03% down from last year.
  • As of FY2024, Cytokinetics' Profit After Tax stood at -$589.5 million, which was down 12.03% from -$526.2 million recorded in FY2023.
  • Over the past 5 years, Cytokinetics' Profit After Tax peaked at -$127.3 million during FY2020, and registered a low of -$589.5 million during FY2024.
  • For the 3-year period, Cytokinetics' Profit After Tax averaged around -$501.6 million, with its median value being -$526.2 million (2023).
  • Data for Cytokinetics' Profit After Tax shows a maximum YoY crashed of 80.65% (in 2022) over the last 5 years.
  • Cytokinetics' Profit After Tax (Yearly) stood at -$127.3 million in 2020, then tumbled by 69.15% to -$215.3 million in 2021, then plummeted by 80.65% to -$389.0 million in 2022, then plummeted by 35.30% to -$526.2 million in 2023, then fell by 12.03% to -$589.5 million in 2024.